This study uncovers a novel mechanism by which miR-144 affects the TCA cycle and Nrf2 signalling, suggesting that targeting miR-144 may serve as a potential therapeutic approach to alleviate oxidative stress in obesity-related liver diseases. Here, NFE2L2 is linked to obesity disorder.